Sitemap - 2018 - The California Stem Cell Report
A Deep Probe by STAT into the Man Behind the CRISPR Babies
California Stem Cell Agency Scores 50 Clinical Trials, Says It "Just Getting Started"
Trump, Fetal Tissue and the California Stem Cell Agency
Walking a Thin Line at the California Stem Cell Agency
California Setting Stage for Crackdown on Dubious Stem Cell Clinics
Former Biotech Maven Steve Burrill Sentenced to Prison
California Stem Cell Agency Slated to Award $6.2 Million to Fight Lymphoma
The Valley of Death and the California Stem Cell Agency: Luring Deep Pocket Investors
The Genetically Altered Babies Story: More Information Surfaces on Researcher's California Links
The California Stem Cell Agency Speaks Out on Raelians and New Types of Human Beings
Genetically Altered Babies: A Bit of a California Connection
California Kicks Off Major, New Foray into Gene Therapy: First by Any State in the Country
Combating Stem Cell Snake Oil: A Primer From a California Researcher
California Stem Cell Agency Moving to Expand its Reach into Big Market for Gene Therapy
A $59 Million Matter of Fraud and Hubris: The Anversa Stem Cell Story and Its Fallout
Tax Breaks and $220 Million for California Stem Cell Agency
Autism to Bladder Cancer: California Awards $25.2 Million For Stem Cell Research
$144 Million California Stem Cell Research Program Set for 2019
Where Has The Money Gone? A 10-cent Look at $3 Billion in California Stem Cell Spending
California Stem Cell Agency's Latest Awards: Total of $17 Million for Cancer, Blindness, HIV
Go-ahead Given on $144 Million California Stem Cell Research Budget for Next Year
Stem Cell Scientists' Hopes for Research Cash Survive Another Round in California
Dollars Dribbling Away: California Stem Cell Scientists Appeal for More Research Cash
Major Sickle Cell Surge: Feds and California Collaborate on Cell Therapies for the Disease
The Final $144 Million and the California Stem Cell Agency's Future
Possible Federal Restrictions on Stem Cell Research and the Multi-Billion Dollar California Angle
$10 Million More for Viacyte for a Virtual Stem Cell Cure for Type 1 Diabetes
California's $72 Million Diabetes/Stem Cell Bet: A New Partner from Massachusetts
California's Stem Cell Agency Says It Has Saved Lives and Is Building a Foundation to Save More
California's $50 Million Alpha Network: Managing the Complexity of Stem Cell Clinical Trials
A Global Stem Cell Perspective: CIRM's Accomplishments in a Field Tougher than Rocket Science
SF Chronicle Backs Away From More Cash for California's Stem Cell Agency
California's Stem Cell Agency Touts Its "Incredible Ecosystem" of Research
Yes or No on More Money for California's Stem Cell Program? Your Chance to Vote Today
State Lawmakers Hear Story of a Life-Saving Treatment and the California Stem Cell Agency
Article Postponed on Folsom baby and the Stem Cell Agency
A Harsher Look at California's Stem Cell Program: No More Cash Without Changes
A Before and After Story of $138 Million in California Stem Cell Cash
'Better Than Hope' -- An Advocate's View of California's $3 Billion Stem Cell Research Program
California Stem Cell Agency Touts its Economic Impact on the Golden State
CEO Millan Makes the Case for California's $3 Billion Stem Cell Research Program
A California Stem Cell Tale: The Search for a Treatment for Paralyzing Spinal Injuries
California's Stem Cell 'Gold Rush:' Nearly 14 Years of Prospecting
ACT to Astellas: A 'Looping' Tale of the Stem Cell Industry and Research
California Lawmakers Schedule Update Next Week on the State's $3 Billion Stem Cell Agency
The 'Renegade Outposts' of the Stem Cell Industry: A Sweeping Examination by the SF Chronicle
California Stem Cell Cybercast: Multiplying the CIRM Story
Live Online Event Tomorrow from California Stem Cell Agency: Ask the Experts about ALS
California Stem Cell Agency's Latest Online Event to Highlight ALS and Challenges to Research
Media Series on California Stem Cell Agency Has New Publication Dates
A Good Sign for California's Stem Cell Agency? Californians Like to Say Yes to More Bonds
Expansive Media Series on California's Stem Cell Agency as It Nears Cash Cutoff
Stanford's Weissman Lauds California Stem Cell Agency For Innovation, Critical Financing
Now Official: California Stem Cell Scientist Loses Congressional Race
California Backs Research for Brain Cancer and Parkinson's with $9.5 Million
California's "Huge Ecosystem" for Stem Cells: The View from Europe
New California Stem Cell Agency Board Member: Suzanne Sandmeyer of UC Irvine
Stem Cell 'Ethical Tensions,' Recouping the Public Investment, Affordability and Much More
California Stem Cell 'Renewal:' The Search for More Billions -- And Credit for Results
Not a Dr. Ruth Explainer: California Stem Cell Agency's FAQ
Fire, Fury and $5 Billion: A Mini Preview of a Ballot Campaign for the California Stem Cell Agency
'Spontaneity' Live: A Powerful, Cyberspace PR Tool for California's Cash-Strapped Stem Cell Program?
Viral Power: California Stem Cell Agency Hits 6K with Cyberspace Event on Stroke Therapy
$115 Million Stock Offering by California State-backed Biotech Firm, Forty Seven, Inc.
California Stem Cell Agency and First-of-Kind Fetal Transplant for Fatal Affliction
Incontinence to Cancer: California Kicks in $26 Million for Stem Cell Research
A Stem Cell "Nose Job" and Updates on Regulation of Questionable Stem Cell Clinics
Feds Crack Down on Unregulated 'Stem Cell' Clinics, Including One in California
Removing the Barriers to Widespread Use of Stem Cell Treatments
Golden State's Stem Cell 'Value:' Bubble Boy Disease and Bringing a Therapy to Market
A California Scientist's Eight-Year Journey into the Byways of Dubious 'Stem Cell' Clinics
California Hits More Than Half-Billion Dollars in Stem Cell Clinical Trials
Weighing California's Stem Cell Trials: An Update from the Golden State's Stem Cell Agency
Stem Cell 'Hotbed:' A CIRM Roadshow in Riverside
Media Coverage of Stem Cell Therapy for Blindness Loses Sight of California's $36 Million in Support
$30 Million Cash Infusion for San Diego Firm, On Top of $20 Million from California Stem Cell Agency
Job Openings at California's Stem Cell Agency
New Tool for Wading Through California's $2.5 Billion in Stem Cell Spending
Parkinson's Patient Advocate Pitches for More California Stem Cell Funding
Stem Cell Blog Taking Week Off
California's Alpha Clinic Stem Cell Program Shares Stories and Results Next Month
Potential Death of California Stem Cell Program Hangs Over Its Performance Evaluation
The Good and the Not-So-Good: Excerpts From an Evaluation of the California Stem Cell Agency
California Stem Cell Performance Audits and More: Public Has 16 Golden Opportunities to Weigh In
Aussie Bioethics Web Site Negative on California Stem Cell Royalties
Full Text of Comments Summarized in Sacramento Bee Royalty Article
Sacramento Bee, Royalties and California Stem Cell Payoff
California Politics, Stem Cells and Campaign Endorsements
California's Stem Cell Agency Hits 45 Clinical Trials
Counting the Stem Cell Beans: Inside California's First Stem Cell Royalty Check
After 13 years, California Receives Its First Stem Cell Royalty Check
California Stem Cell CEO Millan on What's Missing in CIRM News Coverage
California: Stem Cell Capital of the World? The Perspective from Oakland
Advancing Science, Avoiding Harm: New Fed Rules to Raise Curtain on Clinical Trial Results
Millions, Billions and Babies: The 2017 Stem Cell Story from California
The Unregulated Stem Cell Wildfire: Fresh Look at Practices Not Approved by the FDA
California's Stem Cell Story Gains National Attention on NPR
A Man Named Lucas and the Future of the California Stem Cell Agency
California Makes a $25 Million Kidney Transplant Wager: Its 44th Stem Cell Clinical Trial
A Look at Whether California's Stem Cell Agency Can Carry the Day Two Years From Now
California Stem Cell Spending: Priming a $1.5 Billion Research Influx
California Pumping $19 Million More into Stem Cell Effort to Improve Kidney Transplant Success
California Stem Cells, 'Rapture' and a $5 Billion Bond Measure
Tracking the $3 Billion California Stem Cell Agency Month by Month